- IBDEI0S3 ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,12644,1,4,0)
- ;;=4^Z20.828
- ;;^UTILITY(U,$J,358.3,12644,2)
- ;;=^5062774
- ;;^UTILITY(U,$J,358.3,12645,0)
- ;;=Z11.52^^49^614^3
- ;;^UTILITY(U,$J,358.3,12645,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12645,1,3,0)
- ;;=3^Screening,COVID-19
- ;;^UTILITY(U,$J,358.3,12645,1,4,0)
- ;;=4^Z11.52
- ;;^UTILITY(U,$J,358.3,12645,2)
- ;;=^5160186
- ;;^UTILITY(U,$J,358.3,12646,0)
- ;;=Z13.6^^49^614^4
- ;;^UTILITY(U,$J,358.3,12646,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12646,1,3,0)
- ;;=3^Screening,Cardiovascular Disease
- ;;^UTILITY(U,$J,358.3,12646,1,4,0)
- ;;=4^Z13.6
- ;;^UTILITY(U,$J,358.3,12646,2)
- ;;=^5062707
- ;;^UTILITY(U,$J,358.3,12647,0)
- ;;=Z13.1^^49^614^5
- ;;^UTILITY(U,$J,358.3,12647,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12647,1,3,0)
- ;;=3^Screening,Diabetes Mellitus
- ;;^UTILITY(U,$J,358.3,12647,1,4,0)
- ;;=4^Z13.1
- ;;^UTILITY(U,$J,358.3,12647,2)
- ;;=^5062700
- ;;^UTILITY(U,$J,358.3,12648,0)
- ;;=Z13.220^^49^614^6
- ;;^UTILITY(U,$J,358.3,12648,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12648,1,3,0)
- ;;=3^Screening,Lipoid Disorders
- ;;^UTILITY(U,$J,358.3,12648,1,4,0)
- ;;=4^Z13.220
- ;;^UTILITY(U,$J,358.3,12648,2)
- ;;=^5062702
- ;;^UTILITY(U,$J,358.3,12649,0)
- ;;=Z12.39^^49^614^7
- ;;^UTILITY(U,$J,358.3,12649,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12649,1,3,0)
- ;;=3^Screening,Malig Neop of Breast NEC
- ;;^UTILITY(U,$J,358.3,12649,1,4,0)
- ;;=4^Z12.39
- ;;^UTILITY(U,$J,358.3,12649,2)
- ;;=^5062686
- ;;^UTILITY(U,$J,358.3,12650,0)
- ;;=Z12.5^^49^614^8
- ;;^UTILITY(U,$J,358.3,12650,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12650,1,3,0)
- ;;=3^Screening,Malig Neop of Prostate
- ;;^UTILITY(U,$J,358.3,12650,1,4,0)
- ;;=4^Z12.5
- ;;^UTILITY(U,$J,358.3,12650,2)
- ;;=^5062688
- ;;^UTILITY(U,$J,358.3,12651,0)
- ;;=Z12.12^^49^614^9
- ;;^UTILITY(U,$J,358.3,12651,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12651,1,3,0)
- ;;=3^Screening,Malig Neop of Rectum
- ;;^UTILITY(U,$J,358.3,12651,1,4,0)
- ;;=4^Z12.12
- ;;^UTILITY(U,$J,358.3,12651,2)
- ;;=^5062682
- ;;^UTILITY(U,$J,358.3,12652,0)
- ;;=Z11.1^^49^614^10
- ;;^UTILITY(U,$J,358.3,12652,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12652,1,3,0)
- ;;=3^Screening,Respiratory Tuberculosis
- ;;^UTILITY(U,$J,358.3,12652,1,4,0)
- ;;=4^Z11.1
- ;;^UTILITY(U,$J,358.3,12652,2)
- ;;=^5062670
- ;;^UTILITY(U,$J,358.3,12653,0)
- ;;=Z11.59^^49^614^11
- ;;^UTILITY(U,$J,358.3,12653,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12653,1,3,0)
- ;;=3^Screening,Viral Diseases NEC
- ;;^UTILITY(U,$J,358.3,12653,1,4,0)
- ;;=4^Z11.59
- ;;^UTILITY(U,$J,358.3,12653,2)
- ;;=^5062675
- ;;^UTILITY(U,$J,358.3,12654,0)
- ;;=99212^^50^615^2
- ;;^UTILITY(U,$J,358.3,12654,1,0)
- ;;=^358.31IA^2^2
- ;;^UTILITY(U,$J,358.3,12654,1,1,0)
- ;;=1^SF MDM or 10-19 mins
- ;;^UTILITY(U,$J,358.3,12654,1,2,0)
- ;;=2^99212
- ;;^UTILITY(U,$J,358.3,12655,0)
- ;;=99213^^50^615^3
- ;;^UTILITY(U,$J,358.3,12655,1,0)
- ;;=^358.31IA^2^2
- ;;^UTILITY(U,$J,358.3,12655,1,1,0)
- ;;=1^Low Complex MDM or 20-29 mins
- ;;^UTILITY(U,$J,358.3,12655,1,2,0)
- ;;=2^99213
- ;;^UTILITY(U,$J,358.3,12656,0)
- ;;=99214^^50^615^4
- ;;^UTILITY(U,$J,358.3,12656,1,0)
- ;;=^358.31IA^2^2
- ;;^UTILITY(U,$J,358.3,12656,1,1,0)
- ;;=1^Mod Complex MDM or 30-39 mins
- ;;^UTILITY(U,$J,358.3,12656,1,2,0)
- ;;=2^99214
- ;;^UTILITY(U,$J,358.3,12657,0)
- ;;=99215^^50^615^5
- ;;^UTILITY(U,$J,358.3,12657,1,0)
- ;;=^358.31IA^2^2
- ;;^UTILITY(U,$J,358.3,12657,1,1,0)
- ;;=1^High Complex MDM or 40-54 mins
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0S3 3750 printed Feb 18, 2025@23:21:03 Page 2
- IBDEI0S3 ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,12644,1,4,0)
- +2 ;;=4^Z20.828
- +3 ;;^UTILITY(U,$J,358.3,12644,2)
- +4 ;;=^5062774
- +5 ;;^UTILITY(U,$J,358.3,12645,0)
- +6 ;;=Z11.52^^49^614^3
- +7 ;;^UTILITY(U,$J,358.3,12645,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,12645,1,3,0)
- +10 ;;=3^Screening,COVID-19
- +11 ;;^UTILITY(U,$J,358.3,12645,1,4,0)
- +12 ;;=4^Z11.52
- +13 ;;^UTILITY(U,$J,358.3,12645,2)
- +14 ;;=^5160186
- +15 ;;^UTILITY(U,$J,358.3,12646,0)
- +16 ;;=Z13.6^^49^614^4
- +17 ;;^UTILITY(U,$J,358.3,12646,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,12646,1,3,0)
- +20 ;;=3^Screening,Cardiovascular Disease
- +21 ;;^UTILITY(U,$J,358.3,12646,1,4,0)
- +22 ;;=4^Z13.6
- +23 ;;^UTILITY(U,$J,358.3,12646,2)
- +24 ;;=^5062707
- +25 ;;^UTILITY(U,$J,358.3,12647,0)
- +26 ;;=Z13.1^^49^614^5
- +27 ;;^UTILITY(U,$J,358.3,12647,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,12647,1,3,0)
- +30 ;;=3^Screening,Diabetes Mellitus
- +31 ;;^UTILITY(U,$J,358.3,12647,1,4,0)
- +32 ;;=4^Z13.1
- +33 ;;^UTILITY(U,$J,358.3,12647,2)
- +34 ;;=^5062700
- +35 ;;^UTILITY(U,$J,358.3,12648,0)
- +36 ;;=Z13.220^^49^614^6
- +37 ;;^UTILITY(U,$J,358.3,12648,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,12648,1,3,0)
- +40 ;;=3^Screening,Lipoid Disorders
- +41 ;;^UTILITY(U,$J,358.3,12648,1,4,0)
- +42 ;;=4^Z13.220
- +43 ;;^UTILITY(U,$J,358.3,12648,2)
- +44 ;;=^5062702
- +45 ;;^UTILITY(U,$J,358.3,12649,0)
- +46 ;;=Z12.39^^49^614^7
- +47 ;;^UTILITY(U,$J,358.3,12649,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,12649,1,3,0)
- +50 ;;=3^Screening,Malig Neop of Breast NEC
- +51 ;;^UTILITY(U,$J,358.3,12649,1,4,0)
- +52 ;;=4^Z12.39
- +53 ;;^UTILITY(U,$J,358.3,12649,2)
- +54 ;;=^5062686
- +55 ;;^UTILITY(U,$J,358.3,12650,0)
- +56 ;;=Z12.5^^49^614^8
- +57 ;;^UTILITY(U,$J,358.3,12650,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,12650,1,3,0)
- +60 ;;=3^Screening,Malig Neop of Prostate
- +61 ;;^UTILITY(U,$J,358.3,12650,1,4,0)
- +62 ;;=4^Z12.5
- +63 ;;^UTILITY(U,$J,358.3,12650,2)
- +64 ;;=^5062688
- +65 ;;^UTILITY(U,$J,358.3,12651,0)
- +66 ;;=Z12.12^^49^614^9
- +67 ;;^UTILITY(U,$J,358.3,12651,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,12651,1,3,0)
- +70 ;;=3^Screening,Malig Neop of Rectum
- +71 ;;^UTILITY(U,$J,358.3,12651,1,4,0)
- +72 ;;=4^Z12.12
- +73 ;;^UTILITY(U,$J,358.3,12651,2)
- +74 ;;=^5062682
- +75 ;;^UTILITY(U,$J,358.3,12652,0)
- +76 ;;=Z11.1^^49^614^10
- +77 ;;^UTILITY(U,$J,358.3,12652,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,12652,1,3,0)
- +80 ;;=3^Screening,Respiratory Tuberculosis
- +81 ;;^UTILITY(U,$J,358.3,12652,1,4,0)
- +82 ;;=4^Z11.1
- +83 ;;^UTILITY(U,$J,358.3,12652,2)
- +84 ;;=^5062670
- +85 ;;^UTILITY(U,$J,358.3,12653,0)
- +86 ;;=Z11.59^^49^614^11
- +87 ;;^UTILITY(U,$J,358.3,12653,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,12653,1,3,0)
- +90 ;;=3^Screening,Viral Diseases NEC
- +91 ;;^UTILITY(U,$J,358.3,12653,1,4,0)
- +92 ;;=4^Z11.59
- +93 ;;^UTILITY(U,$J,358.3,12653,2)
- +94 ;;=^5062675
- +95 ;;^UTILITY(U,$J,358.3,12654,0)
- +96 ;;=99212^^50^615^2
- +97 ;;^UTILITY(U,$J,358.3,12654,1,0)
- +98 ;;=^358.31IA^2^2
- +99 ;;^UTILITY(U,$J,358.3,12654,1,1,0)
- +100 ;;=1^SF MDM or 10-19 mins
- +101 ;;^UTILITY(U,$J,358.3,12654,1,2,0)
- +102 ;;=2^99212
- +103 ;;^UTILITY(U,$J,358.3,12655,0)
- +104 ;;=99213^^50^615^3
- +105 ;;^UTILITY(U,$J,358.3,12655,1,0)
- +106 ;;=^358.31IA^2^2
- +107 ;;^UTILITY(U,$J,358.3,12655,1,1,0)
- +108 ;;=1^Low Complex MDM or 20-29 mins
- +109 ;;^UTILITY(U,$J,358.3,12655,1,2,0)
- +110 ;;=2^99213
- +111 ;;^UTILITY(U,$J,358.3,12656,0)
- +112 ;;=99214^^50^615^4
- +113 ;;^UTILITY(U,$J,358.3,12656,1,0)
- +114 ;;=^358.31IA^2^2
- +115 ;;^UTILITY(U,$J,358.3,12656,1,1,0)
- +116 ;;=1^Mod Complex MDM or 30-39 mins
- +117 ;;^UTILITY(U,$J,358.3,12656,1,2,0)
- +118 ;;=2^99214
- +119 ;;^UTILITY(U,$J,358.3,12657,0)
- +120 ;;=99215^^50^615^5
- +121 ;;^UTILITY(U,$J,358.3,12657,1,0)
- +122 ;;=^358.31IA^2^2
- +123 ;;^UTILITY(U,$J,358.3,12657,1,1,0)
- +124 ;;=1^High Complex MDM or 40-54 mins